[symposium-profile]
Profile
Recent Posts
- Combination treatment can reduce rehospitalization risk in PAH: Study
- Targeting gut microbes may be strategy for PAH treatment: Study
- Liquidia working to bring Yutrepia to US market after FDA approval
- Low-dose metformin reformulation shows promise in PAH rats
- Phase 2b trial plans for CS1 as PAH treatment endorsed by FDA